99 related articles for article (PubMed ID: 15158099)
1. Imatinib-mesylate for all patients with hypereosinophilic syndrome?
Musto P; Perla G; Minervini MM; Carella AM; Coco FL; Catalano G
Leuk Res; 2004 Jul; 28(7):773-4. PubMed ID: 15158099
[No Abstract] [Full Text] [Related]
2. Imatinib therapy in Hypereosinophilic Syndrome: a case of molecular remission.
Cervetti G; Galimberti S; Carulli G; Petrini M
Leuk Res; 2005 Sep; 29(9):1097-8. PubMed ID: 16038739
[No Abstract] [Full Text] [Related]
3. Two novel imatinib-responsive PDGFRA fusion genes in chronic eosinophilic leukaemia.
Curtis CE; Grand FH; Musto P; Clark A; Murphy J; Perla G; Minervini MM; Stewart J; Reiter A; Cross NC
Br J Haematol; 2007 Jul; 138(1):77-81. PubMed ID: 17555450
[TBL] [Abstract][Full Text] [Related]
4. Long-term remission of lymphocytic hypereosinophilic syndrome with imatinib mesylate.
Christoforidou A; Kotsianidis I; Margaritis D; Anastasiadis A; Douvali E; Tsatalas C
Am J Hematol; 2012 Jan; 87(1):131-2. PubMed ID: 21919038
[No Abstract] [Full Text] [Related]
5. [Idiopathic hypereosinophilic syndrome: toward a new molecular-targeted therapy and a new cytomorphological and molecular definition].
Moles MP; Landry J; Roche-Lestienne C; Godon A; Schmidt-Tanguy A; Gardembas M; Le Clech C; Verret JL; Zandecki M; Blanchet O
Ann Biol Clin (Paris); 2005; 63(3):317-22. PubMed ID: 15951264
[TBL] [Abstract][Full Text] [Related]
6. Bullous pemphigoid associated with hypereosinophilic syndrome: simultaneous response to imatinib.
Hofmann SC; Technau K; Müller AM; Lübbert M; Bruckner-Tuderman L
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S68-72. PubMed ID: 17097375
[TBL] [Abstract][Full Text] [Related]
7. Treatment of idiopathic hypereosinophilic syndrome with imatinib mesylate.
Garg A; Duggal L; Aggarwal S; Jain N
J Assoc Physicians India; 2006 Nov; 54():883-6. PubMed ID: 17249259
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic remission with imatinib therapy in hypereosinophilic syndrome with trisomy 8 and resolution of severe cardiac dysfunction.
Onitilo AA; Kio EA; Singh AK; Lazarchick J
Leuk Lymphoma; 2005 Nov; 46(11):1667-70. PubMed ID: 16236620
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment with imatinib mesylate of hypereosinophilic syndrome (chronic eosinophilic leukemia) with myelofibrosis.
Ishii Y; Ito Y; Kuriyama Y; Tauchi T; Ohyashiki K
Leuk Res; 2004 May; 28 Suppl 1():S79-80. PubMed ID: 15036947
[No Abstract] [Full Text] [Related]
10. The hypereosinophilic syndrome and the biology of cancer.
Schwartz RS
N Engl J Med; 2003 Mar; 348(13):1199-200. PubMed ID: 12660383
[No Abstract] [Full Text] [Related]
11. Sustained molecular response with imatinib in a leukemic form of idiopathic hypereosinophilic syndrome in relapse after allograft.
Rose C; Dupire S; Roche-Lestienne C; Grardel N; Bourgeois E; Cambier N; Preudhomme C
Leukemia; 2004 Feb; 18(2):354-5. PubMed ID: 14671642
[No Abstract] [Full Text] [Related]
12. Effective treatment of hypereosinophilic syndrome with imatinib mesylate.
Salem Z; Zalloua PA; Chehal A; Bitar N; Abboud M; Kadri A; Chami B; Bazarbachi A
Hematol J; 2003; 4(6):410-2. PubMed ID: 14671612
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of idiopathic hypereosinophilic syndrome with imatinib].
Sørensen AL; Larsen H
Ugeskr Laeger; 2008 Jan; 170(4):254. PubMed ID: 18282461
[TBL] [Abstract][Full Text] [Related]
14. Imatinib mesylate treatment in two patients with idiopathic hypereosinophilic syndrome.
Payne SM; Kovacs MJ
Ann Pharmacother; 2004; 38(7-8):1215-8. PubMed ID: 15187212
[TBL] [Abstract][Full Text] [Related]
15. Soft tissue and skeletal involvement in FIP1L1-PDGFR-alpha positive chronic eosinophilic leukemia: imatinib mesylate may induce complete molecular and imaging remission.
Malagola M; Martinelli G; Rondoni M; Ottaviani E; Piccaluga PP; Ricci P; Visani G; Baccarani M
Haematologica; 2004 Aug; 89(8):ECR25. PubMed ID: 15339694
[No Abstract] [Full Text] [Related]
16. Imatinib mesylate for the treatment of hypereosinophilic syndromes.
Antoniu SA
Curr Opin Investig Drugs; 2006 Nov; 7(11):980-4. PubMed ID: 17117585
[TBL] [Abstract][Full Text] [Related]
17. Case report: rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate.
Schaller JL; Burkland GA
MedGenMed; 2001 Sep; 3(5):9. PubMed ID: 11698916
[TBL] [Abstract][Full Text] [Related]
18. Transient response to imatinib in a chronic eosinophilic leukemia associated with ins(9;4)(q33;q12q25) and a CDK5RAP2-PDGFRA fusion gene.
Walz C; Curtis C; Schnittger S; Schultheis B; Metzgeroth G; Schoch C; Lengfelder E; Erben P; Müller MC; Haferlach T; Hochhaus A; Hehlmann R; Cross NC; Reiter A
Genes Chromosomes Cancer; 2006 Oct; 45(10):950-6. PubMed ID: 16845659
[TBL] [Abstract][Full Text] [Related]
19. Hypereosinophilic syndrome.
Roufosse FE; Goldman M; Cogan E
N Engl J Med; 2003 Jun; 348(26):2687; author reply 2687. PubMed ID: 12826646
[No Abstract] [Full Text] [Related]
20. Heterogeneity of response to imatinib-mesylate (glivec) in patients with hypereosinophilic syndrome: implications for dosing and pathogenesis.
Musto P; Falcone A; Sanpaolo G; Bodenizza C; Perla G; Minervini MM; Cascavilla N; Dell'Olio M; La Sala A; Mantuano S; Melillo L; Nobile M; Scalzulli PR; Bisceglia M; Carella AM
Leuk Lymphoma; 2004 Jun; 45(6):1219-22. PubMed ID: 15360005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
